Longport, Inc. (OTC PK: LPTI), a medical technology specialist in high frequency high resolution ultrasound imaging, today announced the implementation of a pilot project at Wesley Health Care Center, a 356-bed long-term nursing care provider in Saratoga Springs, New York. This project is specifically designed to explore the cost benefit of using the EPISCAN I-200 for pressure ulcer detection and prevention. The principal investigator, Ronald Shannon, MPH, will explore the use of Longport's EPISCAN I-200 for improved clinical detection of pressure ulcer risk and the subsequent reduction of wound care costs. Mr. Shannon is the President of Global Health Economics Projects. Mr. Shannon said, "The timing is right for a cost-effective, diagnostic tool that will give early insight into non-visible pressure ulcer injury so treatment and prevention can begin early. The morbidity associated with the development of pressure ulcers increases patient suffering, nurses' workload and risk of death. Pressure ulcers also increase the length of stay and resultant expense of hospitalization, hardly affordable consequences in today's era of health care economics." Wesley Health Care Center, part of The Wesley Community, operates under the umbrella of services sponsored by United Methodist Health and Housing. For over 34 years, Wesley Health Care Center has taken a leadership role in new healthcare technology initiatives to improve the quality of life of its residents. Wesley involves staff, residents, and families in a partnership of care giving it an environment based on quality, compassion, and excellence. Cindy Labish, RN, MS, CWOCN, Director of Nursing for Wesley Health Care Center, and a certified wound ostomy continence nurse, said, "We are happy to partner with Longport Inc. in this pilot program for preventive wound care. Early detection gives Wesley an enormous advantage in the prevention of pressure ulcers and enables us to have far better outcomes in the care of our residents. Finally, my staff is able to see actual evidence of the effectiveness of their hard work in prevention and this is exciting for us all. We believe that our work on this project will not only benefit Wesley's residents, but help all nursing home residents in the future." For more information about The Wesley Community, please contact Deborah Crotty, Director of Marketing, at 518-587-3600, extension 1564. Connie Phillips-Jones, RN, MSN, Director of Clinical Support, said, "This initiative is a part of Longport, Inc.'s strategy for clinical study support to open new markets using evidence-based information." About Longport, Inc. Longport, Inc. of Glen Mills, Pennsylvania, is a medical technology company that specializes in high resolution ultrasound imaging. After several years and a multi-million dollar investment in the technology, Longport has secured patents, copyrights, and FDA permission to market. The Company's technology has been used to engineer a unique high resolution ultrasound imaging system. For further information please contact Longport, Inc. at 1-800-289-6863 or visit our website at www.longportinc.com. Forward-looking Information and the Private Securities Litigation Reform Act of 1995 Certain statements in this press release, including statements concerning product development milestones and anticipated events, are "forward-looking statements" within the Private Litigation Reform Act of 1995. Forward Looking Statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect Longport's actual results include, among others, uncertainties as to the Company's ability to manage potential problems, delays or anticipated expenses, including problems, delays or expenses involving manufacturing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only to the date of this release. Reference is made to Longport's 2004 annual report on Form 10-K filed with the Securities and Exchange Commission for a more definitive description of such factors. Longport, Inc. undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.
Longport (CE) (USOTC:LPTI)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Longport (CE) 차트를 더 보려면 여기를 클릭.
Longport (CE) (USOTC:LPTI)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Longport (CE) 차트를 더 보려면 여기를 클릭.